Considerations on the Lifespan from Diagnosis to Death in Alzheimer’s Disease
Gavril Cornutiu, Oana Let-Cornutiu
Journal of Advances in Medicine and Medical Research · pp. 1–7 · Published 28 Oct 2015
10.9734/BJMMR/2016/21800Abstract
Background: Evolution of Alzheimer’s disease from the onset of dementia to death is estimated by different authors as lasting between a few months and 21 years. Objective: To verify whether there is an explanation for this dispersion of evolution of cases, starting only from clinical information. Methods: A number of 75 cases of patients dead between 01. Jan. 2011 and 31. Dec. 2012 were analyzed. Data on deaths was collected from the County’s Statistics Institute; other information was collected from patient charts. Results: Gender, onset age, co-morbidities and treatment do not influence the dispersion of cases. Dispersion started at less than one month from diagnosis and ended 11.42 years after diagnosis. At the age of 65, a boom in incidence of dementia symptoms as a stage of the disease was recorded. Dispersion of cases was divided into 3 evolution groups: the majority between 0-3 years, followed by 3-6 years and 6-11.42 years, as a Gaussian curve. Conclusions: 1. The age of 64-65 may be considered a high risk age and it should be monitored accordingly. 2. The question of how just was Kraepelin’s disjunction into pre-senile and senile dementias arises. In terms of evolution, according to dispersion, there are versions of the same disease or different diseases in pathogenesis depth, but similar in symptomatology.
Cited by 0
No indexed citations yet.
Related research
- Regions and Sub-regions Dysfunctions in Alzheimer’s during Rest — shares topic coverage
- An Overview on the Aetiology and Treatment of Alzheimer's Disease — shares topic coverage
- Dementia Diagnosis and Alternate Treatment: A Recent Update on Treatment Options — shares topic coverage
- The Brain Cholinergic System in Neurodegenerative Diseases — shares topic coverage
- Synthesis and Development of BACE 1 Inhibitor for Alzheimer’s Diseases from Medicinal Plants — shares topic coverage
Article metrics
Real usage data collected on this platform.
16
Page views
0
PDF downloads
1
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.